Financials
Financial year 2025
PHARMACIE DU BON PASTEUR from Mons, company number BE0808953175, closed financial year 2025 with a result of € 272,852 after tax. For that financial year PHARMACIE DU BON PASTEUR recorded a gross margin of € 628,336 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 323,197 to € 272,852. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 1.3 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 272,852
▼ 16% vs 2024
Profit after tax over the fiscal year.
€ 348,316
▼ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 250,000 paid out
92 % of the profit went to the shareholders, mostly to HEDERA (67 % of the shares). That is where the money ends up.
People and assets in 2025
2.9
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 167,102
▲ 28% vs 2024
€ 57,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 832,411
▲ € 821,873 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.6 million
▲ € 1.6 million vs 2024
€ 60,709 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.
€ 229,644
▲ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,708
▼ 15% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 600,825 | € 448,142 | € 558,941 | € 628,336 | ▲ 12% |
| Profit after taxes | € 268,063 | € 194,916 | € 323,197 | € 272,852 | ▼ 16% |
| Equity | € 1,324,751 | € 1,069,666 | € 1,242,863 | € 1,265,715 | ▲ 2% |
| Total debts | € 536,465 | € 443,018 | € 429,083 | € 2,399,544 | ▲ € 2 million |
| Cash | € 1,179,735 | € 595,979 | € 436,044 | € 348,316 | ▼ 20% |
| Land & buildings | € 256,983 | € 379,411 | € 356,838 | € 1,455,240 | ▲ € 1.1 million |
| Retained profit | € 1,034,751 | € 779,666 | € 952,863 | € 975,715 | ▲ 2% |
| Dividend | € 3,000 | € 450,000 | € 150,000 | € 250,000 | ▲ 67% |
| Bank debt | € 99,557 | € 69,845 | € 43,603 | € 1,647,504 | ▲ € 1.6 million |
| Balance sheet total | € 1,861,216 | € 1,512,684 | € 1,671,946 | € 3,665,259 | ▲ 119% |
| Employees (FTE) | 3.7 | 2.8 | 3.1 | 2.9 | ▼ 0.2 |
Key figures of PHARMACIE DU BON PASTEUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DU BON PASTEUR?
What happened at PHARMACIE DU BON PASTEUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 272,852 (▼ 16% vs 2024). Source: NBB ↗
- HEDERA SRL became a director. NBB
- Charlotte CHEVALIER became a director. NBB
- ALEPHAR SRL became a director. NBB
- New establishment in Mons. KBO
- Start of the company according to the CBE. KBO
In short
From € 268,063 profit in 2022 to € 272,852 profit in 2025.
Paid € 235,420 in corporate taxes since 2022.
Best year ever: 2024, with € 323,197 profit.
On average € 216,700 of value added per employee in 2025.
A new publication or filing at PHARMACIE DU BON PASTEUR? We notify you, reason included.
Follow PHARMACIE DU BON PASTEURDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of HEDERA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DU BON PASTEURBehind PHARMACIE DU BON PASTEUR are HEDERA SRL, Charlotte CHEVALIER and ALEPHAR SRL. The shares are held by HEDERA (66.5%).
Directors
According to the 2025 annual accounts
Director
since 2023
since 2023
Director
since 2023
Shareholders
66.5%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée du Roeulx 282
7000 Mons
Chaussée du Roeulx 316 box D
7000 Mons
Active since 1 January 2009
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0808.953.175
- VAT number
- BE 0808.953.175
- Registered office
- Chaussée du Roeulx 282, 7000 Mons
- Names & denominations
- PHARMACIE DU BON PASTEUR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 December 2008
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels